Thursday, February 2, 2012

Overreacting to a Prostate Cancer Drug?

Medivation shares are soaring on positive test results. But investors may be
getting ahead of reality here.

No comments:

Post a Comment

LinkWithin

Related Posts Plugin for WordPress, Blogger...